发明公开
EP2046355A2 REDUCED ISOALPHA ACID BASED PROTEIN KINASE MODULATION CANCER TREATMENT
审中-公开
减少ISOALPHA酸蛋白激酶调节癌症治疗
- 专利标题： REDUCED ISOALPHA ACID BASED PROTEIN KINASE MODULATION CANCER TREATMENT
- 专利标题（中）： 减少ISOALPHA酸蛋白激酶调节癌症治疗
-
申请号： EP07809708.6申请日： 2007-06-20
-
公开(公告)号： EP2046355A2公开(公告)日： 2009-04-15
- 发明人: TRIPP, Matthew, L. , BABISH, John, G. , BLAND, Jeffrey , HALL, Amy, Jennae , KONDA, Veera , PACIORETTY, Linda , DESAI, Anu
- 申请人： Metaproteomics, LLC
- 申请人地址： 100 Avenida La Pata San Clemente, CA 92673 US
- 专利权人： Metaproteomics, LLC
- 当前专利权人： Metaproteomics, LLC
- 当前专利权人地址： 100 Avenida La Pata San Clemente, CA 92673 US
- 代理机构： Hill, Justin John
- 优先权： US815064P 20060620
- 国际公布： WO2007149480 20071227
- 主分类号： A61K36/18
- IPC分类号： A61K36/18 ; A61K35/00
摘要：
Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on reduced isoalpha acids, commonly found in hops.
信息查询
